Jung‐Hyun Yang

1.1k total citations
18 papers, 918 citations indexed

About

Jung‐Hyun Yang is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jung‐Hyun Yang has authored 18 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Jung‐Hyun Yang's work include Silymarin and Mushroom Poisoning (4 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Jung‐Hyun Yang is often cited by papers focused on Silymarin and Mushroom Poisoning (4 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Jung‐Hyun Yang collaborates with scholars based in South Korea and United States. Jung‐Hyun Yang's co-authors include Seok Jin Nam, Jeong Eon Lee, Jung‐Han Kim, Sangmin Kim, Jae Hyuck Choi, Jun‐Ho Choe, Wan Wook Kim, Jee Soo Kim, Yoon‐La Choi and Se-Kyung Lee and has published in prestigious journals such as Cancer Research, Molecules and Journal of Ethnopharmacology.

In The Last Decade

Jung‐Hyun Yang

18 papers receiving 896 citations

Peers

Jung‐Hyun Yang
Yayun Liang United States
Reba Mustafi United States
Linda Beltrán United States
Seung‐Nam Jung South Korea
Maria Simonsson Sweden
Zongfu Pan China
Zheng Liu China
Evelyn Tran United States
Harold J. Ting United States
Yayun Liang United States
Jung‐Hyun Yang
Citations per year, relative to Jung‐Hyun Yang Jung‐Hyun Yang (= 1×) peers Yayun Liang

Countries citing papers authored by Jung‐Hyun Yang

Since Specialization
Citations

This map shows the geographic impact of Jung‐Hyun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Hyun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Hyun Yang more than expected).

Fields of papers citing papers by Jung‐Hyun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Hyun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Hyun Yang. The network helps show where Jung‐Hyun Yang may publish in the future.

Co-authorship network of co-authors of Jung‐Hyun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Hyun Yang. A scholar is included among the top collaborators of Jung‐Hyun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Hyun Yang. Jung‐Hyun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Kim, Sangmin, Jeonghun Han, Se Kyung Lee, et al.. (2011). Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells. Cancer Letters. 314(2). 147–154. 22 indexed citations
3.
Kim, Sangmin, Jeonghun Han, Jung‐Han Kim, et al.. (2011). Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells.. PubMed. 31(11). 3767–73. 36 indexed citations
4.
Choi, Yoon‐La, Melanie Bocanegra, Mi Kwon, et al.. (2010). LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer. Cancer Research. 70(6). 2296–2306. 126 indexed citations
5.
6.
Lee, Se Kyung, Eun Yoon Cho, Wan Wook Kim, et al.. (2010). The prediction of lymph node metastasis in ductal carcinoma in situ with microinvasion by assessing lymphangiogenesis. Journal of Surgical Oncology. 102(3). 225–229. 14 indexed citations
7.
Kim, Sangmin, Min Gew Choi, Se Kyung Lee, et al.. (2009). Silibinin Suppresses TNF-α-Induced MMP-9 Expression in Gastric Cancer Cells through Inhibition of the MAPK Pathway. Molecules. 14(11). 4300–4311. 50 indexed citations
8.
Kim, Sangmin, Jae Hyuck Choi, Hye In Lim, et al.. (2009). Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells. Phytomedicine. 16(6-7). 573–580. 80 indexed citations
9.
Choi, Jae Hyuck, Hye In Lim, Se Kyung Lee, et al.. (2009). The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: Comparison with ultrasonography and magnetic resonance imaging. Journal of Surgical Oncology. 102(5). 392–397. 40 indexed citations
10.
Kim, Sangmin, Sung Hoon Kim, Sung Mo Hur, et al.. (2009). Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells. Journal of Ethnopharmacology. 126(2). 252–257. 47 indexed citations
11.
Kim, Sangmin, Jae Hyuck Choi, Hye In Lim, et al.. (2009). EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line. Cellular Signalling. 21(6). 892–898. 74 indexed citations
12.
Kim, Sangmin, Jae Hyuck Choi, Jong Bin Kim, et al.. (2008). Berberine Suppresses TNF-α-induced MMP-9 and Cell Invasion through Inhibition of AP-1 Activity in MDA-MB-231 Human Breast Cancer Cells. Molecules. 13(12). 2975–2985. 113 indexed citations
13.
Kim, Hyun Jung, Young‐Hyuck Im, Boo‐Kyung Han, et al.. (2007). Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: Relation to response patterns on MRI. Acta Oncologica. 46(7). 996–1003. 68 indexed citations
14.
Choi, Young‐Jin, Seok Jin Nam, Myung Jin Son, et al.. (2006). Erlotinib prevents pulmonary metastasis in curatively resected breast carcinoma using a mouse model. Oncology Reports. 16(1). 119–22. 8 indexed citations
15.
Kim, Jeong Han, et al.. (2004). 갑상선 수질암 환자에서 칼시토닌 정상화와 관련된 예후인자. Journal of the Korean Surgical Society. 66(4). 301–306. 2 indexed citations
16.
Han, Seong‐Su, Kihyun Kım, Eun‐Ryeong Hahm, et al.. (2004). L‐ascorbic acid represses constitutive activation of NF‐κB and COX‐2 expression in human acute myeloid leukemia, HL‐60. Journal of Cellular Biochemistry. 93(2). 257–270. 38 indexed citations
17.
Oh, Young Lyun, Jong Sun Choi, Sang‐Yong Song, et al.. (2001). Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status. Pathology International. 51(2). 94–99. 47 indexed citations
18.
Hahm, Jong Ryeal, Myung‐Shik Lee, Yong‐Ki Min, et al.. (2001). Routine Measurement of Serum Calcitonin is Useful for Early Detection of Medullary Thyroid Carcinoma in Patients with Nodular Thyroid Diseases. Thyroid. 11(1). 73–80. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yayun Liang Breakdown of academic impact, for papers by Reba Mustafi Breakdown of academic impact, for papers by Linda Beltrán Breakdown of academic impact, for papers by Seung‐Nam Jung Breakdown of academic impact, for papers by Maria Simonsson Breakdown of academic impact, for papers by Zongfu Pan Breakdown of academic impact, for papers by Zheng Liu Breakdown of academic impact, for papers by Evelyn Tran Breakdown of academic impact, for papers by Harold J. Ting
Rankless by CCL
2026